Skip to main content

Table 2 Clinical data of infants carrying the m.1555A>G-genotype

From: Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants

Number Birth weight category [grams] Gestational age [weeks] Gender [m/f] Mutliple [y/n] Gentamicin treatment [y/n] Result of hearing screening
1 1100-1199 28 M Y Y Pass
2 1100-1199 28 M Y Y Pass
3 800-899 25 F N Y Pass
4 1200-1299 29 M N N Pass
5 1200-1299 32 F N N Pass
6 1200-1299 29 F Y Y Pass
7 800-899 29 F Y Y Fail
8 1400-1499 32 M N Y Pass
9 1300-1399 30 M N Y Pass
10 1400-1499 30 F Y Y Pass
11 1300-1399 30 F Y Y Fail
12 <400 24 M N Y Fail
  1. Birth weight and gestational age are given as completed 100 grams/completed weeks, respectively. All aminoglycoside treated infants received gentamicin. Patients 1 and 2, 6 and 7 and patients 10 and 11 were twin pairs. None of the patients was treated with furosemide.